The spectrum of coagulation abnormalities in thyroid disorders

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 1, 2011, Pages 7-10

  Vescovi, Pier Paolo ^a   Favaloro, Emmanuel J ^b   Lippi, Giuseppe ^c   Garofano, Massimo ^a   Montagnana, Martina ^d   Manzato, Franco ^a   Franchini, Massimo ^c  

^a CARLO POMA HOSPITAL   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Bleeding; hyperthyroidism; hypothyroidism; thrombosis

Indexed keywords

ADRENALIN; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8C; BLOOD CLOTTING FACTOR 9; COLLAGEN; D DIMER; FIBRINOGEN; LEVOTHYROXINE; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR; RISTOCETIN; THYROID HORMONE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GRAVES DISEASE; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTHYROIDISM; HYPOTHYROIDISM; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROTHROMBIN TIME; THROMBOCYTOPENIC PURPURA; THYROID DISEASE; THYROIDECTOMY; VENOUS THROMBOEMBOLISM; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HUMANS; THYROID DISEASES;

EID: 79251500999     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270065     Document Type: Article

References (46)

1. Franchini M, Lippi G, Manzato F, Vescovi P P., Targher G. Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol 2010 162 3 439-451
2. Squizzato A, Gerdes V EA, Ageno W, Bller H R. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2007 2 2 76-83
3. Squizzato A, Romualdi E, Bller H R., Gerdes V EA. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007 92 7 2415-2420
4. Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest 2004 27 9 886-892
5. Franchini M, Montagnana M, Manzato F, Vescovi P P. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost 2009 35 3 288-294
6. Mina A, Favaloro E J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost 2007 33 8 798-809
7. Marongiu F, Barcellona D, Mameli A, Mariotti S. Thyroid disorders and hypocoagulability. Semin Thromb Hemost 2011 37 1 11-16
8. Erem C. Thyroid disorders and hypercoagulability. Semin Thromb Hemost 2011 37 1 17-26
9. Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine 2009 36 1 110-118
10. Ford H C., Carter J M. Haemostasis in hypothyroidism. Postgrad Med J 1990 66 774 280-284
11. Erem C, Kavgaci H, Ersz H O. et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003 57 2 78-81
12. Hofbauer L C., Heufelder A E. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997 136 1 1-7
13. Marongiu F, Cauli C, Mariotti S. Thyroid, hemostasis and thrombosis. J Endocrinol Invest 2004 27 11 1065-1071
14. Dalton R G., Dewar M S., Savidge G F. et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987 1 8540 1007-1009
15. Blesing N E., Hambley H, McDonald G A. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J 1990 66 776 474-476
16. Thornton J G., Parapia L A., Minford A MB. Hypothyroidism and von Willebrand's disease. Lancet 1987 1 8545 1314-1315
17. Nitu-Whalley I C., Lee C A. Acquired von Willebrand syndromereport of 10 cases and review of the literature. Haemophilia 1999 5 5 318-326
18. Michiels J J., Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001 7 2 113-115
19. Attivissimo L A., Lichtman S M., Klein I. Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995 5 5 399-401
20. Tjan-Heijnen V CG, Harthoorn-Lasthuizen E J., Kurstjens R MA, Koolen M I. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. Neth J Med 1994 44 3 91-94
21. Franchini M, de Gironcoli M, Lippi G et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haemophilia 2002 8 2 142-144
22. Manfredi E, van Zaane B, Gerdes V E., Brandjes D P., Squizzato A. Hypothyroidism and acquired von Willebrand's syndrome: a systematic review. Haemophilia 2008 14 3 423-433
23. Franchini M, Zugni C, Veneri D et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004 89 11 1341-1346
24. Palareti G, Biagi G, Legnani C et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989 62 4 1053-1056
25. Myrup B, Bregengrd C, Faber J. Primary haemostasis in thyroid disease. J Intern Med 1995 238 1 59-63
26. Egeberg B O. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 1963 15 1-7
27. Rogers J S. II, Shane S R., Jencks F S. Factor VIII activity and thyroid function. Ann Intern Med 1982 97 5 713-716
28. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005 152 3 355-361
29. Meiklejohn D J., Watson H G. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001 7 5 523-525
30. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001 86 2 732-737
31. Cantrk Z, Cetinarslan B, Tarkun I, Cantrk N Z., Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2003 13 10 971-977 (Pubitemid 37351881)
32. zcan M A., Cmleki A, Demirkan F et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 2003 110 4 243-247
33. Ochs N, Auer R, Bauer D C. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008 148 11 832-845
34. Duntas L, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost 2011 37 1 27-34
35. Hofbauer L C., Spitzweg C, Schmauss S, Heufelder A E. Graves' disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 1997 157 9 1033-1036
36. Cordiano I, Betterle C, Spadaccino C A., Soini B, Girolami A, Fabris F. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 1998 113 3 373-378
37. Franchini M, Lippi G, Manzato F, Vescovi P P. Thyroid-associated autoimmune coagulation disorders. J Thromb Thrombolysis 2010 29 1 87-91
38. Marongiu F, Conti M, Murtas M L. et al. Anticardiolipin antibodies in Graves' disease: relationship with thrombin activity in vivo. Thromb Res 1991 64 6 745-749
39. Hofbauer L C., Spitzweg C, Heufelder A E. Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996 23 8 1435-1437
40. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007 92 8 3006-3012
41. Rogers J S. II, Shane S R. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983 102 3 444-449
42. Lippi G, Franchini M, Targher G et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis 2009 28 3 362-365
43. Franchini M, Lippi G, Targher G. Hyperthyroidism and venous thrombosis: a causal or casual association? A systematic literature review. Clin Appl Thromb Hemost 2010 March 22 (Epub ahead of print)
44. Erem C, Ersz H O., Karti S S. et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002 25 4 345-350
45. Morishita E, Hashimoto T, Asakura H et al. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease. Thromb Haemost 1998 79 5 919-923
46. Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz H O. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. Endocrine 2009 36 3 473-478